SG Americas Securities’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $267M | Buy |
427,703
+269,425
| +170% | +$183M | 0.15% | 99 |
|
|
2026
Q1 | $122M | Buy |
158,278
+27,166
| +21% | +$20.8M | 0.13% | 131 |
|
|
2025
Q4 | $101M | Buy |
131,112
+118,690
| +955% | +$80.6M | 0.13% | 125 |
|
|
2025
Q3 | $6.99M | Sell |
12,422
-3,610
| -23% | -$2.04M | 0.02% | 412 |
|
|
2025
Q2 | $8.42M | Sell |
16,032
-48,031
| -75% | -$26.8M | 0.04% | 347 |
|
|
2025
Q1 | $40.6M | Buy |
64,063
+62,122
| +3,201% | +$42.7M | 0.13% | 107 |
|
|
2024
Q4 | $1.38M | Sell |
1,941
-21,414
| -92% | -$18M | 0.01% | 725 |
|
|
2024
Q3 | $24.6M | Sell |
23,355
-17,056
| -42% | -$19M | 0.09% | 131 |
|
|
2024
Q2 | $42.5M | Buy |
40,411
+29,901
| +285% | +$29M | 0.25% | 83 |
|
|
2024
Q1 | $10.1M | Buy |
10,510
+3,235
| +44% | +$3.08M | 0.05% | 362 |
|
|
2023
Q4 | $6.39M | Sell |
7,275
-16,866
| -70% | -$13.9M | 0.06% | 289 |
|
|
2023
Q3 | $19.9M | Sell |
24,141
-20,021
| -45% | -$15.7M | 0.23% | 72 |
|
|
2023
Q2 | $31.7M | Buy |
44,162
+17,037
| +63% | +$13.1M | 0.24% | 51 |
|
|
2023
Q1 | $22.3M | Buy |
27,125
+4,384
| +19% | +$3.31M | 0.26% | 62 |
|
|
2022
Q4 | $16.4M | Buy |
22,741
+10,452
| +85% | +$7.71M | 0.2% | 88 |
|
|
2022
Q3 | $8.47M | Buy |
12,289
+5,154
| +72% | +$3.24M | 0.1% | 167 |
|
|
2022
Q2 | $4.22M | Sell |
7,135
-1,167
| -14% | -$759K | 0.04% | 357 |
|
|
2022
Q1 | $5.8M | Sell |
8,302
-1,598
| -16% | -$1.01M | 0.04% | 360 |
|
|
2021
Q4 | $6.25M | Buy |
9,900
+6,942
| +235% | +$4.27M | 0.03% | 405 |
|
|
2021
Q3 | $1.79M | Sell |
2,958
-17,368
| -85% | -$10.8M | 0.01% | 1378 |
|
|
2021
Q2 | $11.4M | Buy |
20,326
+7,151
| +54% | +$3.62M | 0.05% | 301 |
|
|
2021
Q1 | $6.23M | Sell |
13,175
-4,915
| -27% | -$2.39M | 0.03% | 431 |
|
|
2020
Q4 | $8.74M | Sell |
18,090
-6,880
| -28% | -$3.71M | 0.05% | 296 |
|
|
2020
Q3 | $14M | Buy |
24,970
+7,974
| +47% | +$4.83M | 0.09% | 157 |
|
|
2020
Q2 | $10.6M | Buy |
16,996
+3,500
| +26% | +$1.99M | 0.09% | 159 |
|
|
2020
Q1 | $6.59M | Buy |
13,496
+2,433
| +22% | +$1M | 0.06% | 298 |
|
|
2019
Q4 | $4.15M | Sell |
11,063
-34,248
| -76% | -$11.5M | 0.04% | 466 |
|
|
2019
Q3 | $12.6M | Sell |
45,311
-46,010
| -50% | -$13.6M | 0.1% | 187 |
|
|
2019
Q2 | $28.6M | Buy |
91,321
+64,442
| +240% | +$21.5M | 0.2% | 87 |
|
|
2019
Q1 | $11M | Buy |
26,879
+12,141
| +82% | +$5M | 0.1% | 201 |
|
|
2018
Q4 | $5.5M | Sell |
14,738
-14,557
| -50% | -$5.33M | 0.05% | 352 |
|
|
2018
Q3 | $11.8M | Buy |
29,295
+24,705
| +538% | +$9.4M | 0.09% | 237 |
|
|
2018
Q2 | $1.58M | Sell |
4,590
-13,830
| -75% | -$4.33M | 0.01% | 1087 |
|
|
2018
Q1 | $6.34M | Buy |
18,420
+8,378
| +83% | +$2.91M | 0.05% | 325 |
|
|
2017
Q4 | $3.77M | Sell |
10,042
-106
| -1% | -$42.9K | 0.04% | 513 |
|
|
2017
Q3 | $4.54M | Sell |
10,148
-17,160
| -63% | -$8.17M | 0.04% | 382 |
|
|
2017
Q2 | $13.4M | Buy |
27,308
+13,333
| +95% | +$5.83M | 0.12% | 161 |
|
|
2017
Q1 | $5.42M | Sell |
13,975
-7,954
| -36% | -$2.95M | 0.05% | 359 |
|
|
2016
Q4 | $8.05M | Buy |
21,929
+16,293
| +289% | +$6.2M | 0.07% | 287 |
|
|
2016
Q3 | $2.27M | Sell |
5,636
-11,244
| -67% | -$4.51M | 0.02% | 666 |
|
|
2016
Q2 | $5.89M | Sell |
16,880
-11,233
| -40% | -$4.33M | 0.04% | 352 |
|
|
2016
Q1 | $10.1M | Sell |
28,113
-19,385
| -41% | -$7.99M | 0.07% | 208 |
|
|
2015
Q4 | $25.8M | Sell |
47,498
-103,097
| -68% | -$55.9M | 0.18% | 94 |
|
|
2015
Q3 | $39.3M | Buy |
150,595
+82,835
| +122% | +$44.5M | 0.24% | 76 |
|
|
2015
Q2 | $34.6M | Buy |
67,760
+19,946
| +42% | +$9.73M | 0.23% | 66 |
|
|
2015
Q1 | $21.6M | Sell |
47,814
-44,392
| -48% | -$18.8M | 0.13% | 135 |
|
|
2014
Q4 | $37.8M | Sell |
92,206
-12,291
| -12% | -$4.83M | 0.19% | 102 |
|
|
2014
Q3 | $37.7M | Sell |
104,497
-31,425
| -23% | -$10.5M | 0.22% | 96 |
|
|
2014
Q2 | $38.4M | Buy |
135,922
+34,600
| +34% | +$10.3M | 0.22% | 89 |
|
|
2014
Q1 | $30.4M | Buy |
101,322
+369
| +0.4% | +$114K | 0.13% | 175 |
|
|
2013
Q4 | $27.8M | Sell |
100,953
-45,562
| -31% | -$13.1M | 0.12% | 174 |
|
|
2013
Q3 | $45.8M | Buy |
146,515
+34,293
| +31% | +$9.02M | 0.19% | 106 |
|
|
2013
Q2 | $25.2M | Buy |
+112,222
| New | +$26.1M | 0.12% | 154 |
|
Other funds holding REGN
SG Americas Securities's REGN Position: Q2 2026 in Review
SG Americas Securities increased its Regeneron Pharmaceuticals (REGN) stake by 170% in Q2 2026, buying an estimated $183M and bringing the position to 427,703 shares worth $267M. The position accounts for 0.15% of the portfolio, ranked #99.
SG Americas Securities first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- SG Americas Securities held 427,703 shares of Regeneron Pharmaceuticals worth $267M as of Q2 2026.
- SG Americas Securities bought 269,425 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $183M.
- Regeneron Pharmaceuticals made up 0.15% of SG Americas Securities's portfolio in Q2 2026, its #99 holding.
- SG Americas Securities first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.